Ledger.Open graph →
SEC Form D · Amendment · filed April 24, 2017

Lyric Pharmaceuticals Inc

Offering
$33.9M
Sold
$26.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Niall O'Donnell · San Francisco, CADirectorJason Hong · South San Francisco, CADirectorDavid Wurtman · South San Francisco, CAExec · DirectorM. S. Harris · South San Francisco, CAExecSanford Zweifach · South San Francisco, CADirectorTony Chou · San Jose, CADirectorRohit Vishnoi · San Jose, CADirectorLeslie J. Trigg · San Jose, CAExecCasey Cunningham · Austin, TXDirectorJosh Elman · San Francisco, CADirectorKurt Koschnitzke · NEW YORK, NYExec · DirectorGregory Gentile · NEW YORK, NYExecMicroVest GMG Capital Management, LLC · New York, NYDirectorGil Crawford · NEW YORK, NYExec · DirectorCasey Cunningham · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗